Podcast Journal Club

Stages of Cystic Fibrosis-Related Diabetes

March 26, 2021

EFL011

Join host Dr. Chase Hendrickson, Vanderbilt University Medical Center, regular contributor Dr. Rich Comi, Fellowship Program Director and Section Cheif for Endocrinology at Dartmouth Hitchcock Medical Center, and Dr. Kim Donaghue, Conjoint Professor in Child and Adolescent Health at the University of Sydney and Senior Staff Endocrinologist at the Children's Hospital at Westmead, as they discuss a recent article from the Journal of Clinical Endocrinology & Metabolism (JCEM), "Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function."

Click here to login and listen to the episode!

Meet the Speakers

Rich Comi, MD, is a Professor of Medicine at the Geisel School of Medicine at Dartmouth, Section Chief of Endocrinology and the Program Director for the endocrinology fellowship program at DHMC. Dr. Comi has been a member of the Department of Medicine at DHMC since 1989. He graduated from Harvard Medical School in 1980, completed his residency in Internal Medicine at the Massachusetts General Hospital in 1983 and did his fellowship in Endocrinology at the National Institutes of Health from 1983-1988. Dr. Comi has been instrumental in developing clinical programs in diabetes management at DHMC and in regional education outreach to disseminate best-practices of complex diabetic care. Dr. Comi was recognized in 2013 for his expertise and dedication to teaching by becoming a member of the Academy of Master Educators in the Geisel School of Medicine at Dartmouth.

Kim Donaghue, MBBS, PhD, FRACP, is Conjoint Professor in Child and Adolescent Health at the University of Sydney and Senior Staff Endocrinologist at the Children’s Hospital at Westmead (CHW), where she was Co-Head of Institute of Endocrinology and Diabetes (2010-2016), and Head of the Diabetes Service (2004 -2010). She is immediate Past President of ISPAD (2020-2021), and was APEG President 2001-2003. She was Foundation Chair of Education for the Australasian Paediatric Endocrine Group (APEG) (2006-2010) and received the APEG Norman Wettenhall Award for Research and Innovation in 2015. She was a Senior Editor for the ISPAD Clinical Practice Consensus Guidelines (2004-09); and currently leads the UpToDate module on cystic fibrosis-related diabetes. Dr. Donaghue has published over 200 peer reviewed manuscripts and book chapters. Her major research focus has been the pathogenesis and intervention for diabetes complications. She serves on the Steering Committee for two international interventional studies to reduce complications: the Adolescent Type 1 Diabetes Cardiorenal Protection Trial (ADDIT), and the FAME-1 Eye Trial. She is currently leading a data linkage project on adult outcomes of childhood-onset diabetes.

Last Updated:
Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!